 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jun 06, 2009 |
| Title |
Cardiac 12/15-lipoxygenase-induced inflammation is involved in heart failure |
| Organism |
Rattus norvegicus |
| Experiment type |
Expression profiling by array
|
| Summary |
To identify a novel target for the treatment of heart failure, we examined gene expression in the failing heart. Among the genes analyzed, 12/15 lipoxygenase (12/15-LOX) was markedly up-regulated in heart failure. To determine whether increased expression of 12/15-LOX causes heart failure, we established transgenic mice that overexpressed 12/15-LOX in cardiomyocytes. Echocardiography showed that 12/15-LOX transgenic mice developed systolic dysfunction. Cardiac fibrosis increased in 12/15-LOX transgenic mice with advancing age, and was associated with the infiltration of macrophages. Consistent with these observations, cardiac expression of monocyte chemoattractant protein-1 (Mcp-1) was up-regulated in 12/15-LOX transgenic mice compared with wild-type mice. Treatment with 12-hydroxy-eicosatetraenotic acid, a major metabolite of 12/15-LOX, increased MCP-1 expression in cardiac fibroblasts and endothelial cells, but not in cardiomyocytes. Inhibition of Mcp-1 reduced the infiltration of macrophages into the myocardium and prevented both systolic dysfunction and cardiac fibrosis in 12/15-LOX transgenic mice. Likewise, disruption of 12/15-LOX significantly reduced cardiac Mcp-1 expression and macrophage infiltration, thereby improving systolic dysfunction induced by chronic pressure overload. Our results suggest that cardiac 12/15-LOX is involved in the development of heart failure and that inhibition of 12/15-LOX could be a novel treatment for this condition.
|
| |
|
| Overall design |
Heart failure is still one of the leading causes of death worldwide. Therefore, it is important to elucidate the underlying mechanisms of heart failure and develop more effective treatments for this condition. To clarify the molecular mechanisms of heart failure, we performed microarray analysis using cardiac tissue samples obtained from a hypertensive heart failure model (Dahl salt-sensitive rats). ~300 genes showed significant changes of expression in the failing hearts compared with control hearts. Among the genes analyzed, 12/15-lipoxygenase (12/15-LOX) was most markedly up-regulated in failing hearts compared with control hearts .
|
| |
|
| Citation(s) |
19546247 |
| Submission date |
May 22, 2009 |
| Last update date |
Feb 21, 2017 |
| Contact name |
Yosuke Kayama |
| E-mail(s) |
yo-yosuke@eos.ocn.ne.jp
|
| Phone |
+81-43-226-2964
|
| Fax |
+81-43-226-2096
|
| Organization name |
Chiba University Graduate School of Medicine
|
| Department |
Cardiovascular Science and Medicine
|
| Street address |
1-8-1 Inohana, Chuo-ku
|
| City |
Chiba |
| State/province |
Chiba |
| ZIP/Postal code |
260-8670 |
| Country |
Japan |
| |
|
| Platforms (1) |
| GPL85 |
[RG_U34A] Affymetrix Rat Genome U34 Array |
|
| Samples (2) |
|
| Relations |
| BioProject |
PRJNA117137 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE16199_RAW.tar |
4.0 Mb |
(http)(custom) |
TAR (of CEL) |
| Processed data included within Sample table |
|
|
|
|
 |
